Editorial policy
Last updated August 20, 2026.
This site makes regulatory, legal and clinical statements about a subject where being approximately right is the same as being wrong. Here is how it is written.
Sourcing
- Regulatory statements come from the primary source — the Patient Safety and Quality Improvement Act of 2005 (42 U.S.C. §§ 299b-21 to 299b-26), the Patient Safety Rule (42 C.F.R. Part 3), AHRQ’s own published material, and CareGuard’s own listing record and AHRQ correspondence.
- Facts about CareGuard’s listing come from the AHRQ listing and the listing approval letter, not from recollection. The public listing.
- The checklist figures come from the checklist. 189 items, 54 categories. No other number is used anywhere on this site.
- Missouri reporting contacts come from the Missouri Department of Health and Senior Services and were verified against health.mo.gov before publication.
- Clinical statements name their evidence — the FDA label change of February 28, 2012 on statins and glycemia; Sattar et al., The Lancet, 2010; the 2024 individual-participant-data meta-analysis in The Lancet Diabetes & Endocrinology; the AGS Beers Criteria; STOPP/START version 3 (2023); STOPPFrail.
Vocabulary this site will not use
CareGuard does not certify, accredit or license anything, and told AHRQ so on its listing form. The words “certified”, “certification” and “accredited” are therefore not used to describe CareGuard, a review, or a facility that has had one — including in headings, alt text and structured data. The nouns are safety review, facility safety assessment and patient safety review. Why we stopped saying “certified”.
For the same reason this site does not describe CareGuard as Medicare-listed or Medicare-certified (Medicare does not list PSOs), does not call it a PEO, and does not describe it as a nursing home.
What this site does not do
- It does not publish prices and does not promise a financial result to any facility.
- It does not give legal advice or medical advice.
- It does not assert a regulatory consequence it has not verified against a source.
- It does not name or describe an identifiable resident, employee or facility.
Authorship and review
Content is published by CareGuard. Clinical positions — on deprescribing, on antihypertensives and falls, on statins and glycemia, on restraints — are those of Dr. Gurpreet Singh Padda, MD, MBA, MHP, the Authorized Official of CareGuard. About Dr. Padda.
Corrections
If something here is wrong, tell us and it will be corrected on the page rather than quietly removed. seva@padda.com. A known discrepancy is already disclosed on the PSO P0268 page: the mailing address on the AHRQ listing is CareGuard’s former office, and a change-of-listing notice is in preparation.
Machine readers
A structured summary of this site, including the guardrails above, is published at /llms.txt alongside the XML sitemap.